Matches in SemOpenAlex for { <https://semopenalex.org/work/W2415171421> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2415171421 endingPage "32" @default.
- W2415171421 startingPage "325" @default.
- W2415171421 abstract "To assess the response and the impact on the overall survival (OS) on c-KIT-positive (CD117+) gastrointestinal stromal tumours (GISTs) patients treated with imatinib mesylate.Between July 2003 and December 2012, consenting patients with advanced c-kit-positive GISTs were enrolled to receive imatinib mesylate therapy at a dose of 400mg - 800mg daily, supplied gratis by Novartis Pharma (Basel, Switzerland) under its GIPAP initiative. Disease severity was based on tumour site, size and mitotic index at diagnosis. Clinical features together with drug toxicity, haematological and biochemical parameters were monitored. Overall survival (OS) reviewed at 12 months intervals over 5 years was computed using Kaplan-MeierThere were 27 patients in all (17 males and 10 females with a median age of 52 years (range 26 - 83). Twenty three patients, 15 males and 8 females that have been followed up for at least 6 months were evaluated, aged 26-83 years (median = 56). There were 17 (73.9%) gastric tumours and 6 extragastric including 3 cases of peritoneum and 1 each of small gut, colon and rectum. At diagnosis, 21 (91.3%) cases were high risk, and 1 each fell into the intermediate and low risks, respectively. Ten patients (43.4%) including 5 with metastases presented with unresectable lesions. Five patients (21.7%) had complete tumour resection, 5 (3 with metastases) had partial resections and 3 others with non-bulky, nonmetastatic diseases underwent no surgery. Imatinib was used as the primary therapy for all patients, except the 5 patients that underwent complete tumour resection. Nine (39.1%) patients were lost to disease progression with a median survival of 16.7 +/- 10.7 (+/- SE) (95% CI = 0-37.6) months. The overall survival at 2 years for all patients was 71.9%, which dropped to 65.9% at 4 years.Although a small number of GISTs, imatinib induced an extended remission in patients with advanced disease, most of whom would have been dead within a few months of diagnosis." @default.
- W2415171421 created "2016-06-24" @default.
- W2415171421 creator A5008536379 @default.
- W2415171421 creator A5010069134 @default.
- W2415171421 creator A5014624535 @default.
- W2415171421 creator A5032314949 @default.
- W2415171421 creator A5032380678 @default.
- W2415171421 creator A5050219778 @default.
- W2415171421 creator A5060395647 @default.
- W2415171421 creator A5066463373 @default.
- W2415171421 creator A5075579490 @default.
- W2415171421 creator A5078782780 @default.
- W2415171421 creator A5087668133 @default.
- W2415171421 date "2013-12-01" @default.
- W2415171421 modified "2023-09-23" @default.
- W2415171421 title "Imatinib (Glivec) and gastrointestinal stromal tumours in Nigerians." @default.
- W2415171421 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24839736" @default.
- W2415171421 hasPublicationYear "2013" @default.
- W2415171421 type Work @default.
- W2415171421 sameAs 2415171421 @default.
- W2415171421 citedByCount "0" @default.
- W2415171421 crossrefType "journal-article" @default.
- W2415171421 hasAuthorship W2415171421A5008536379 @default.
- W2415171421 hasAuthorship W2415171421A5010069134 @default.
- W2415171421 hasAuthorship W2415171421A5014624535 @default.
- W2415171421 hasAuthorship W2415171421A5032314949 @default.
- W2415171421 hasAuthorship W2415171421A5032380678 @default.
- W2415171421 hasAuthorship W2415171421A5050219778 @default.
- W2415171421 hasAuthorship W2415171421A5060395647 @default.
- W2415171421 hasAuthorship W2415171421A5066463373 @default.
- W2415171421 hasAuthorship W2415171421A5075579490 @default.
- W2415171421 hasAuthorship W2415171421A5078782780 @default.
- W2415171421 hasAuthorship W2415171421A5087668133 @default.
- W2415171421 hasConcept C10205521 @default.
- W2415171421 hasConcept C126322002 @default.
- W2415171421 hasConcept C141071460 @default.
- W2415171421 hasConcept C16930146 @default.
- W2415171421 hasConcept C2775922572 @default.
- W2415171421 hasConcept C2776839831 @default.
- W2415171421 hasConcept C2777583451 @default.
- W2415171421 hasConcept C2778729363 @default.
- W2415171421 hasConcept C2781074409 @default.
- W2415171421 hasConcept C28328180 @default.
- W2415171421 hasConcept C3019892230 @default.
- W2415171421 hasConcept C54355233 @default.
- W2415171421 hasConcept C71924100 @default.
- W2415171421 hasConcept C86803240 @default.
- W2415171421 hasConcept C90924648 @default.
- W2415171421 hasConceptScore W2415171421C10205521 @default.
- W2415171421 hasConceptScore W2415171421C126322002 @default.
- W2415171421 hasConceptScore W2415171421C141071460 @default.
- W2415171421 hasConceptScore W2415171421C16930146 @default.
- W2415171421 hasConceptScore W2415171421C2775922572 @default.
- W2415171421 hasConceptScore W2415171421C2776839831 @default.
- W2415171421 hasConceptScore W2415171421C2777583451 @default.
- W2415171421 hasConceptScore W2415171421C2778729363 @default.
- W2415171421 hasConceptScore W2415171421C2781074409 @default.
- W2415171421 hasConceptScore W2415171421C28328180 @default.
- W2415171421 hasConceptScore W2415171421C3019892230 @default.
- W2415171421 hasConceptScore W2415171421C54355233 @default.
- W2415171421 hasConceptScore W2415171421C71924100 @default.
- W2415171421 hasConceptScore W2415171421C86803240 @default.
- W2415171421 hasConceptScore W2415171421C90924648 @default.
- W2415171421 hasIssue "4" @default.
- W2415171421 hasLocation W24151714211 @default.
- W2415171421 hasOpenAccess W2415171421 @default.
- W2415171421 hasPrimaryLocation W24151714211 @default.
- W2415171421 hasRelatedWork W1989294227 @default.
- W2415171421 hasRelatedWork W2012444260 @default.
- W2415171421 hasRelatedWork W2014183075 @default.
- W2415171421 hasRelatedWork W2026821399 @default.
- W2415171421 hasRelatedWork W2039425886 @default.
- W2415171421 hasRelatedWork W2040507859 @default.
- W2415171421 hasRelatedWork W2118628315 @default.
- W2415171421 hasRelatedWork W2124283114 @default.
- W2415171421 hasRelatedWork W2462478674 @default.
- W2415171421 hasRelatedWork W3029187455 @default.
- W2415171421 hasVolume "42" @default.
- W2415171421 isParatext "false" @default.
- W2415171421 isRetracted "false" @default.
- W2415171421 magId "2415171421" @default.
- W2415171421 workType "article" @default.